Here’s what you should know:
1. The capsule monitors unexpected bleeding in postsurgical patients.
2. If a physician suspects GI bleeding, the capsule detects it quickly.
3. EnteraSense won a European Union Horizon 2020 grant and secured private investor funding.
4. EnteraSense will conduct in-human studies in 2019, with the goal of earning regulatory approval in 2020.
More articles on gastroenterology:
The PE arms race — From the deal heard round the world to what’s next in GI
The strategy behind Pardee UNC’s $16M ASC
ASC supply chain tip of the day: Find an accountability structure
